公告指出，此次预期收入增长主要得益于公司"熟人医患关系"模式、AI技术带来的升级，吸引了更多医 生与患者的进驻，进而带动面向消费者的业务持续增长。扭亏为盈主要是由于收入增长，以及以权益结 算以股份为基础的交易减少，推动公司实现从亏损到盈利的质变。 方舟健客（06086）早盘涨超36%，截至发稿，股价上涨36.39%，现报3.86港元，成交额1.70亿港元。 1月25日，方舟健客发布2025年正面盈利预告。正面盈利预告显示，公司预计营收实现35-35.5亿元，同 比增长约30%；在利润端，继2024年实现经调整层面盈利后，公司2025年预计实现净利润700-1000万 元，正式达成全面盈利。 ...

公告指出，此次预期收入增长主要得益于公司"熟人医患关系"模式、AI技术带来的升级，吸引了更多医 生与患者的进驻，进而带动面向消费者的业务持续增长。扭亏为盈主要是由于收入增长，以及以权益结 算以股份为基础的交易减少，推动公司实现从亏损到盈利的质变。 方舟健客(06086)涨超35%，截至发稿，涨35.84%，报3.83港元，成交额1.34亿港元。 消息面上，1月25日，方舟健客发布2025年正面盈利预告。正面盈利预告显示，公司预计营收实现35- 35.5亿元，同比增长约30%；在利润端，继2024年实现经调整层面盈利后，公司2025年预计实现净利润 700-1000万元，正式达成全面盈利。 ...

公告指出，此次预期收入增长主要得益于公司"熟人医患关系"模式、AI技术带来的升级，吸引了更多医 生与患者的进驻，进而带动面向消费者的业务持续增长。扭亏为盈主要是由于收入增长，以及以权益结 算以股份为基础的交易减少，推动公司实现从亏损到盈利的质变。 消息面上，1月25日，方舟健客发布2025年正面盈利预告。正面盈利预告显示，公司预计营收实现35- 35.5亿元，同比增长约30%；在利润端，继2024年实现经调整层面盈利后，公司2025年预计实现净利润 700-1000万元，正式达成全面盈利。 智通财经APP获悉，方舟健客(06086)涨超35%，截至发稿，涨35.84%，报3.83港元，成交额1.34亿港 元。 ...

Group 1 - The city council received a total of 1318 proposals from 610 members during the recent session, reflecting active participation and engagement in local governance [1] - Proposals focus on key areas such as urban governance, public welfare, cultural tourism integration, and the development of new productive forces, indicating a trend towards cross-sector collaboration and forward-thinking planning [3] - A proposal was made to utilize AI technology to prevent telecom fraud targeting the elderly, highlighting the vulnerability of this demographic and the need for a comprehensive prevention system [1] Group 2 - A proposal was submitted to enhance the China Open tennis tournament, aiming to position it as the fifth largest tennis event globally, which would support Beijing's development as an international sports city [2] - The proposal emphasizes the importance of optimizing event positioning, marketing, and product development to increase the tournament's global presence and cultural significance [2] - The initiative aligns with Beijing's broader strategy to strengthen its status as a center for international exchanges and events [2]

点击小程序查看报告原文 公募基金四季度仓位变动：股票仓位有所下降；A股仓位上升，港股继续下降 2025年四季度，A股整体窄幅震荡。11月中上旬，受中美关系阶段性缓和与"十五五"政策预期带动，上证指数一度刷新年内高点；其后在美联储降息节奏 反复、市场对AI估值泡沫担忧升温等因素扰动下，风险偏好有所回落；至12月中旬跨年行情启动，市场再度走强。总体来看，四季度上证指数上涨 2.2%；前期表现强势的成长风格回调，科创50下跌10.1%，跌幅靠前，创业板指收跌1.1%；偏大盘的上证50上涨1.4%而沪深300微跌0.2%；偏中小盘的中 证1000和中证2000分别上涨0.3%和3.6%；红利风格有所表现，中证红利指数上涨0.8%。在此背景下，主动偏股型公募基金单季度收益率中位数为-1.5%， 较上季度显著下降，单季收益为年内最低。 公募基金资产规模继续扩张，权益资产占比下降，债券资产占比回升。 公募基金整体资产规模连续三个季度扩张，四季度资产总值由上季度的38.1万亿元 升至39.5万亿元。其中，股票资产规模小幅上升至9万亿元以上，股票占资产总值的比重较上季度下降0.7个百分点至22.9%；债券资产占比较上季度上升 ...

1月25日，据韩国媒体报道，三星电子在今年第一季度将NAND闪存的供应价格上调了100%以上，这一 涨幅远超市场此前预期，凸显了当前半导体市场严重的供需失衡现状。 报道称，三星已于2025年年底完成与主要客户的供应合同谈判，1月起正式实施新价格体系，目前已启 动二季度价格谈判，市场普遍预计涨势将延续。这一消息标志着存储行业全面进入涨价上行周期，对全 球半导体产业链及A股相关标的将产生深远影响。 招商证券表示，截至2026年1月，全球存储产业（以SSD/NANDFlash为主，兼顾DRAM）正处在一轮明 显的涨价上行期，与过去"消费旺季—补库存"式的短周期波动不同，本轮更像结构性紧缺。 此次NAND涨价并非孤立事件，核心源于供需两端的剧烈失衡。需求端，AI技术的爆发式增长成为核心 驱动力，生成式AI向代理型系统进化带来海量数据存取需求，显著推升高IOPS企业级SSD需求；同 时"端侧AI"落地倒逼手机、PC等终端升级高容量存储。 供给端，头部厂商此前投资保守，未进行大规模扩产，叠加制程升级带来的产能置换效应，有效供给严 重不足。东方证券指出，AI需求推动下，NAND与SSD供不应求有望持续，行业供需缺口短期内难 ...

Core Viewpoint - BOE Technology Group has launched the HERO 2.0 smart cockpit at CES 2026, integrating AI technology to enhance audio-visual experiences, interaction methods, and application scenarios, while promoting "vehicle-home connectivity" and "vehicle-business connectivity" through its innovative "domain control cockpit" concept [1]. Group 1: Visual and Audio Experience - The MicroLED PHUD features an ultra-high brightness of 50,000 nits, a wide color gamut of 115% NTSC, and a pixel size of 0.2mm, complemented by a 15.6-inch automotive-grade MLED backlight UB Cell central display with local dimming technology, achieving a million-level ultra-high contrast [2]. - The world's first AI smart car digital amplifier is introduced, equipped with all-scenario noise reduction technology and AI sound quality restoration technology [2]. Group 2: Interaction and Application - The cockpit supports multi-modal interaction methods, including touch, voice, and gesture, allowing users to control various functions such as adjusting the sunroof, regulating air conditioning, ordering takeout, and remotely monitoring home conditions, thus achieving "vehicle-home connectivity" and "vehicle-business connectivity" [2]. - A high-quality smart wood grain table with multi-touch functionality is integrated into the cockpit, enabling users to perform diverse operations such as office PPT presentations and seat massage control [2]. Group 3: Capacity Expansion and Market Position - BOE Technology Group is actively expanding its production capacity, with the groundbreaking of the third phase of the Heyuan manufacturing base on November 23, 2025, which will include automotive display smart production lines, R&D centers, and core laboratories, expected to complete initial equipment installation by November 2026 and achieve large-scale production by December 2026, adding over 10 million units of annual production capacity [3]. - The company has established a global production and supply service system centered around its Heyuan, Chengdu, and Vietnam bases, reinforcing its market leadership in automotive display shipments [3]. Group 4: Share Buyback and Financial Projections - The company announced a share buyback of 500,000 shares for future incentive plans, representing 0.063% of the currently issued shares, with an average buyback price of HKD 4.9 [3]. - Financial projections for BOE Technology Group estimate total revenues of approximately HKD 14 billion, HKD 15.5 billion, and HKD 17.5 billion for 2025-2027, reflecting year-on-year growth of 4%, 10%, and 13%, respectively, while net profit attributable to shareholders is projected at HKD 370 million, HKD 470 million, and HKD 550 million, with a year-on-year change of -5%, +25%, and +17% [3].

Group 1 - The core point of the article is that Jinbo Bio has received approval from the China Securities Regulatory Commission (CSRC) for a targeted stock issuance, marking the first such approval for the Beijing Stock Exchange in 2024, which is expected to enhance the refinancing system for companies listed on the exchange [1][4] - Jinbo Bio plans to issue up to 7.1757 million shares, aiming to raise a total of no more than 2 billion yuan, with the funds primarily directed towards the development of an AI-driven collagen database and product development platform [2][3] - The introduction of Yangshengtang as a strategic investor is expected to help Jinbo Bio overcome development bottlenecks and stimulate the upstream and downstream enterprises in the industry chain [2] Group 2 - The Beijing Stock Exchange has established a flexible and diverse refinancing mechanism since its inception, primarily utilizing methods such as private placements and convertible bonds, with Jinbo Bio's project being a significant breakthrough in the past two years [4] - The successful implementation of Jinbo Bio's stock issuance is anticipated to enhance overall market attention towards companies on the Beijing Stock Exchange, attracting various long-term funds and improving market liquidity and investor returns [5] - This project is expected to provide replicable and referable practical experience for future refinancing efforts on the Beijing Stock Exchange, aligning with its core mission to serve innovative small and medium-sized enterprises [5]

Group 1 - The core point of the article is that Jinbo Bio has received approval from the China Securities Regulatory Commission (CSRC) for a targeted stock issuance, marking the first such approval for the Beijing Stock Exchange in 2024, which is expected to enhance the refinancing system for companies listed on the exchange [1][3] - Jinbo Bio plans to issue up to 7.1757 million shares, aiming to raise no more than 2 billion yuan, with the funds primarily directed towards the development of an AI research platform [1][2] - The strategic investor, Yangshengtang, is expected to help Jinbo Bio overcome development bottlenecks and stimulate the upstream and downstream enterprises in the industry chain [1] Group 2 - The funds raised will focus on the "Humanized Collagen FAST Database and Product Development Platform Project," which utilizes the company's self-developed "AI Collagen Brain System" technology to enhance efficiency in the development of humanized collagen [2] - The Beijing Stock Exchange has established a flexible and diverse refinancing mechanism since its inception, with the current focus on targeted convertible bonds and stock issuance, as evidenced by Jinbo Bio's successful registration [3] - The successful implementation of Jinbo Bio's stock issuance is expected to increase overall market attention on companies listed on the Beijing Stock Exchange, attracting various long-term funds and enhancing market liquidity [4]

经核实，"青岛黄岛区高中生械斗致4人死亡""青岛市黄岛区高中生聚众斗殴"等均为虚假消息，青 岛市黄岛区并未发生相关案件，上述消息系AI技术生成的不实信息。 央视网消息：记者1月25日从山东青岛互联网联合辟谣平台获悉，近日网传"青岛黄岛区高中生械斗 致4人死亡"等信息，系AI技术生成的不实信息。1月24日，一则"青岛黄岛区高中生械斗致4人死亡"的消 息在网络上传播。有网民发布截图称，"今年1月23日晚，青岛黄岛区某中学后方发生械斗，约60名学生 携带管制刀具等参与械斗，致4人死亡、10余人重伤。" ...